Abstract
There are increasing evidence and growing interest in the relationship between protein aggregates/phase separation and various human diseases, especially neurodegenerative diseases. However, we do not entirely comprehend how aggregates generate or the clearance network of chaperones, proteasomes, ubiquitin ligases, and other factors interact with aggregates. Here, we describe chemically controllable systems compose with a genetically engineered cell and a small drug that enables us to rapidly induce protein aggregates’ formation by withdrawing the small molecule. This trigger does not activate global stress responses induced by stimuli, such as proteasome inhibitors or heat shock. This method can produce aggregates in a specific compartment and diverse experimental systems, including live animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Annu Rev Biochem 78:959–991
Douglas PM, Dillin A (2010) Protein homeostasis and aging in neurodegeneration. J Cell Biol 190(5):719–729
Morimoto RI (2011) The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol 76:91–99
Dubnikov T, Ben-Gedalya T, Cohen E (2017) Protein quality control in health and disease. Cold Spring Harb Perspect Biol 9(3):a023523
Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11(11):777–788
Chen B, Retzlaff M, Roos T, Frydman J (2011) Cellular strategies of protein quality control. Cold Spring Harb Perspect Biol 3:a004374
Kisselev AF, Goldberg AL (2001) Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8:739–758
Kawaguchi Y, Kovacs JJ, Mclaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727–738
Szeto J, Kaniuk NA, Canadien V, Nisman R, Muzushima N, Yoshimori T, Bazett-Jones DP, Brumell JH (2006) ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2:189–199
Miller SB, Ho CT, Winkler J, Khokhrina M, Neuner A, Mohamed MY, Guilbride DL, Richter K, Lisby M, Schiebel E, Mogk A, Bukau B (2015) Compartment-specific aggregases direct distinct nuclear and cytoplasmic aggregate deposition. EMBO J 34:778–797
Bush KT, Goldberg AL, Nigam SK (1997) Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 272:9086–9092
Lee DH, Goldberg AL (1998) Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae. Mol Cell Biol 18:30–38
Kaganovich D, Kopito R, Frydman J (2008) Misfolded proteins partition between two distinct quality control compartments. Nature 454:1088–1095
Bersuker K, Hipp MS, Calamini B, Morimoto RI, Kopito RR (2013) Heat shock response activation exacerbates inclusion body formation in a cellular model of huntington disease. J Biol Chem 288(33):23633–23638
Yu A, Shibata Y, Shah B, Calamini B, Lo DC, Morimoto RI (2014) Protein aggregation can inhibit clathrin-mediated endocytosis by chaperone competition. Proc Natl Acad Sci U S A 111:E1481–E1490
Banaszynski LA, Chen LC, Maynard-Smith LA, Ooi AG, Wandless TJ (2006) A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell 126(5):995–1004
Iwamoto M, Björklund T, Lundberg C, Kirik D, Wandless TJ (2010) A general chemical method to regulate protein stability in the mammalian central nervous system. Chem Biol 17(9):981–988
Miyazaki Y, Imoto H, Chen LC, Wandless TJ (2012) Destabilizing domains derived from the human estrogen receptor. J Am Chem Soc 134(9):3942–3945
Maynard-Smith LA, Chen LC, Banaszynski LA, Ooi AG, Wandless TJ (2007) A directed approach for engineering conditional protein stability using biologically silent small molecules. J Biol Chem 282(34):24866–24872
Knowles TPJ, Vendruscolo M, Dobson CM (2014) The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol 15:384–396
Nakamura H, DeRose R, Inoue T (2019) Harnessing biomolecular condensates in living cells. J Biochem 166(1):13–27
Miyazaki Y, Mizumoto K, Dey G, Kudo T, Perrino J, Chen LC, Meyer T, Wandless TJ (2016) A method to rapidly create protein aggregates in living cells. Nat Commun 7:11689
Egeler EL, Urner LM, Rakhit R, Liu CW, Wandless TJ (2011) Ligand-switchable substrates for a ubiquitin-proteasome system. J Biol Chem 286:31328–31336
Grimley JS, Chen DA, Banaszynski LA, Wandless TJ (2008) Synthesis and analysis of stabilizing ligands for FKBP-derived destabilizing domains. Bioorg Med Chem Lett 18:759–761
Ramdzan YM, Polling S, Chia CPZ, Ng IHW, Ormsby AR, Croft NP, Purcell AW, Bogoyevitch MA, Ng DCH, Gleeson PA, Hatters DM (2012) Tracking protein aggregation and mislocalization in cells with flow cytometry. Nat Methods 9:467–470
Acknowledgments
This work was supported by the NIH (GM073046 and P50 GM107615), the Ellison Medical Foundation (AG-SS-2573-10), and the Stanford Discovery Innovation Fund. Y.M. was supported by the Nakajima Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Miyazaki, Y. (2021). AgDD System: A Chemical Controllable Protein Aggregates in Cells. In: Kojima, R. (eds) Mammalian Cell Engineering. Methods in Molecular Biology, vol 2312. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1441-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1441-9_16
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1440-2
Online ISBN: 978-1-0716-1441-9
eBook Packages: Springer Protocols